Clincosm LogoSign in Get a demo

triple negative breast neoplasms

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Xiaopi granules
  • +2 more
  • (no location specified)
Nov 22, 2023

Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Atezolizumab + RP1
  • Paris, France
    Institut Curie
Oct 2, 2023

Breast Cancer, Inflammatory Breast Cancer Stage IV, Inflammatory Breast Tumors Trial in Knoxville (Self-Administered Hypnosis,

Recruiting
  • Breast Cancer
  • +4 more
  • Self-Administered Hypnosis
  • Self-Administered White Noise Hypnosis
  • Knoxville, Tennessee
    University of Tennessee Knoxville
Sep 26, 2023

Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab injection
  • +2 more
  • (no location specified)
Jul 25, 2023

Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

Recruiting
  • Uterine Cervical Neoplasms
  • +10 more
  • Pembrolizumab/Vibostolimab Co-Formulation
  • +11 more
  • Anchorage, Alaska
  • +65 more
Jan 27, 2023

Triple Negative Breast Tumors Trial in Worldwide (alpelisib, , nab-paclitaxel)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Los Alamitos, California
  • +154 more
Jan 12, 2023

Triple Negative Breast Tumors Trial in Worldwide (Atezolizumab, Placebo, Gemcitabine)

Recruiting
  • Triple Negative Breast Neoplasms
  • Fort Myers, Florida
  • +165 more
Jan 12, 2023

Triple Negative Breast Tumors Trial in Worldwide (ladiratuzumab vedotin, Pembrolizumab)

Recruiting
  • Triple Negative Breast Neoplasms
  • Birmingham, Alabama
  • +49 more
Jan 4, 2023

Advanced Solid Tumor, Urinary Bladder Tumor, Pancreatic Tumors Trial in Worldwide (BT8009, Nivolumab)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Denver, Colorado
  • +20 more
Nov 22, 2022

Triple Negative Breast Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Carboplatin)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab
  • +3 more
  • Monterey, California
  • +121 more
Oct 10, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

Recruiting
  • Ovarian Neoplasms
  • +9 more
  • Aurora, Colorado
  • +6 more
Aug 15, 2022

Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)

Recruiting
  • Clear Cell Renal Cell Cancer
  • +8 more
  • La Jolla, California
  • +22 more
Aug 12, 2022

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

Breast Cancer, Triple Negative Breast Tumors Trial in France (Nivolumab, Ipilimumab, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Triple Negative Breast Neoplasms
  • Angers, France
  • +16 more
Jul 21, 2022

Triple Negative Breast Tumors Trial in Worldwide (Pembrolizumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab
  • +7 more
  • Scottsdale, Arizona
  • +192 more
Jul 8, 2022

Precision Neoadjuvant Triple-negative Breast Cancer Treatment

Recruiting
  • Triple Negative Breast Cancer
  • Triple Negative Breast Neoplasms
  • Core needle biopsy
  • London, United Kingdom
    Barts Health NHS Trust
Jun 22, 2022

Breast Tumors, Triple Negative Breast Tumors Trial in Chicago, Madison (drug, procedure, other)

Terminated
Has Results
  • Breast Neoplasms
  • Triple Negative Breast Neoplasms
  • Chicago, Illinois
  • +1 more
Jun 2, 2022

Breast Cancer, Breast Tumor, Breast Cancer Female Trial in Houston (Paclitaxel, Carboplatin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • +10 more
  • Houston, Texas
  • +1 more
May 15, 2022

Triple Negative Breast Tumors Trial in Italy, United Kingdom (MSB0010718C)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Bergamo, BG, Italy
  • +71 more
Mar 31, 2022

NSCLC, Triple Negative Breast Tumors, Squamous Cell Carcinoma of Head and Neck Trial in United States (Pembrolizumab, TAK-676,

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • West Hollywood, California
  • +5 more
Mar 17, 2022

Triple Negative Breast Tumors Trial in San Francisco, Chicago (350 mg leronlimab, 525 mg leronlimab, 700 mg leronlimab)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • 350 mg leronlimab
  • +4 more
  • San Francisco, California
  • +1 more
Mar 18, 2022

Triple Negative Breast Cancer, Triple Negative Breast Tumors, TNBC - Triple-Negative Breast Cancer Trial in Saint Louis (drug,

Active, not recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 14, 2022

Triple Negative Breast Cancer, Triple Negative Breast Tumors, Triple-Negative Breast Cancer Trial (Personalized synthetic long

Withdrawn
  • Triple Negative Breast Cancer
  • +2 more
  • Personalized synthetic long peptide vaccine (Poly ICLC)
  • Poly ICLC
  • (no location specified)
Mar 9, 2022